Search results
Author(s):
Linda Joosten
Added:
1 year ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial.
FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists …
View more
Author(s):
Renato D Lopes
Added:
8 months ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more
Matthew Dixon
Author
Ken Okumura
Research Area(s) / Expertise:
Author
Michael Fu
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Author
John McNeill
Job title: Professor and head of School of Public Health and Preventive Medicine
Author
Robert H Fagard
Job title: Chief of the Hypertension and Cardiovascular Rehabilitation Unit at the Department of Cardiovascular Diseases, Faculty of Medicine
Author
Prakash Deedwania
Research Area(s) / Expertise:
Job title: Professor of Medicine
Author
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
1 year ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more